Money has been flowing into life sciences, ignited by breakthroughs in immuno-oncology, neonatology and other technological advances.
That investment translates into commercial real estate leasing, according to JLL.
"Every time there is a funding round, it's only a matter of months before these companies are looking for new space," says Travis McCready, executive director, US Life Sciences Markets, JLL in a new report. "When companies get VC money, they need lab space in order to deliver as soon as humanly possible."
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Leslie Shaver
Les Shaver has been covering commercial and residential real estate for almost 20 years. His work has appeared in Multifamily Executive, Builder, units, Arlington Magazine in addition to GlobeSt.com and Real Estate Forum.
